Vivera is an innovative, science-driven pharmaceutical company focused on novel therapies for a variety of indications. In addition to its pharmaceutical, medical device, advanced diagnostics, medical supplies, medical technologies, and neurosciences, the Company has global exclusivity to license the patented and patent-pending TABMELT®️ sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds. Vivera is vertically integrated with technology, manufacturing capabilities, and distribution for its products.
Vivera is committed to the continued research and development of innovative therapies across the spectrum. We believe that now is the time to combat some of the most unprecedented issues affecting patients and their caregivers by redefining the landscape with safe, yet effective, non-addictive treatment alternatives for pain management and the latest in medical device technologies. From strength in vision to channeled realization, we believe the path forward begins with the requirement to put patients first. Our foremost mission is to enhance the lives of millions of neighbors, families, and the leaders of tomorrow, through ceaseless development of life-changing new therapies.
Vivera is dedicated to making a positive difference for vulnerable communities across the world. Through our non-profit organization, Vivera Cares, we are helping underserved communities, like Tribal Nations and frontline workers, access the resources they need to keep their communities safe and healthy. With our continued support, we can envision a brighter future for our communities, patients, and providers.
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company, has welcomed Mr. Shawn Ray to the Company’s Ambassador Board. Mr. Ray will not
Esteemed pharmaceutical expert joins innovative Newport Beach pharmaceutical companyin pursuit of breakthrough medical developments NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical
NEWPORT BEACH, Calif.– Vivera Pharmaceuticals, Inc. is pleased to announce the allowance of its dose-controlled drug delivery device patent for ZICOH®. Designed to better facilitate
NEWPORT BEACH, Calif.– Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company, has named Farah Al Qaissieh to the Ambassador Board of its Neurosciences Division. As
Vivera is excited to attend StutterFEST 2021 this Saturday, May 8! Hosted by the World Stuttering Network, StutterFEST is a 20-hour celebration of the stuttering
Vivera is excited to announce that we will be sponsoring the 17th MHA Business Summit taking place March 24-25, 2021. The MHA Business Summit is
Fentanyl is a fully synthetic opioid that is 50 to 100 times stronger than morphine. Because of its high potency, it is most commonly used
Did you know that between eight and 12 percent of people who are prescribed opioids for chronic pain develop an opioid use disorder? Since opioids activate the
Did you know that people living with chronic pain are four times more likely to experience anxiety or depression than those without chronic pain? Oftentimes, chronic
The opioid epidemic refers to the increasing number of deaths and hospitalizations attributed to opioid misuse. This public health crisis has various costs – in
In the United States, opioids are the leading cause of drug-related deaths – out of the nearly 71,000 people who died from a drug overdose in
Although opioids are commonly prescribed for the treatment of chronic pain, they often come with harmful side effects, and can even lead to dependence or
Innovation is the lifeblood of Vivera. With six divisions, each focused on a specific crisis response, Vivera’s vertically integrated structure has created an agile and responsive model.
Vivera is working to change the future of drug delivery, medical device, and medical technologies at home and across the globe with its extensive intellectual property portfolio.
Copyright © 2021 Vivera Pharmaceuticals, Inc. All rights reserved.
This information – including product information – is intended only for certified clinicians in the United States. The products discussed herein may have different labeling in different countries. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
English
Arabic
Armenian
Chinese (Simplified)
Chinese (Traditional)
Czech
Dutch
Tagalog
French
Frisian
German
Irish
Italian
Korean
Farsi
Polish
Portuguese
Romanian
Russian
Spanish
Swedish
Ukrainian
Vietnamese